BUX.CN
BioMark Diagnostics Inc
Price:  
0.32 
CAD
Volume:  
4,500.00
Canada | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BUX.CN Intrinsic Value

-233.40 %
Upside

What is the intrinsic value of BUX.CN?

As of 2025-06-19, the Intrinsic Value of BioMark Diagnostics Inc (BUX.CN) is (0.43) CAD. This BUX.CN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.32 CAD, the upside of BioMark Diagnostics Inc is -233.40%.

The range of the Intrinsic Value is (2.41) - (0.24) CAD

Is BUX.CN undervalued or overvalued?

Based on its market price of 0.32 CAD and our intrinsic valuation, BioMark Diagnostics Inc (BUX.CN) is overvalued by 233.40%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

0.32 CAD
Stock Price
(0.43) CAD
Intrinsic Value
Intrinsic Value Details

BUX.CN Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (2.41) - (0.24) (0.43) -233.4%
DCF (Growth 10y) (0.26) - (2.40) (0.44) -237.9%
DCF (EBITDA 5y) (0.13) - (0.19) (1,234.50) -123450.0%
DCF (EBITDA 10y) (0.16) - (0.23) (1,234.50) -123450.0%
Fair Value -0.09 - -0.09 -0.09 -128.20%
P/E (0.05) - (0.15) (0.10) -130.0%
EV/EBITDA (0.14) - (0.17) (0.16) -150.0%
EPV (0.13) - (0.17) (0.15) -147.1%
DDM - Stable (0.34) - (4.84) (2.59) -910.1%
DDM - Multi (0.21) - (2.31) (0.39) -221.0%

BUX.CN Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 33.63
Beta -0.30
Outstanding shares (mil) 105.09
Enterprise Value (mil) 34.09
Market risk premium 5.10%
Cost of Equity 5.75%
Cost of Debt 8.63%
WACC 5.77%